TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data ...

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflowData presented at AGBT ...

Rare disease is a major – and growing – area of clinical research and drug development. Of the FDA’s 46 novel drug approvals ...

Illumina introduces TruPath Genome, setting a new standard in genomic insight: San Diego Thursday, February 26, 2026, 16:00 Hrs [IST] Illumina, Inc. announced the launch of TruPat ...

Spread the loveIn the rapidly evolving landscape of health care, the concept of digital twins is emerging as a transformative technology that promises to enhance patient treatment and outcomes.

The Gene Synthesis Market has emerged as one of the most transformative segments within modern biotechnology, driven by rapid ...

Anemia in young adult women is rarely caused by a single factor. Instead, it reflects a layered interaction of nutritional deficiencies, physiological demands, chronic illnesses, genetic ...

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the ...

With an incredibly simple workflow, TruPath Genome eliminates traditional library prep. In just 10-15 minutes of hands-on ...

Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

How is understanding the potential impact of the US Supreme Court’s tariff-related ruling on India-US trade deal relevant to ...